This investment was made when British International Investment was named CDC Group.
Medis produces high quality, affordable medication, particularly for the growing number of patients in the region afflicted with chronic diseases such as diabetes, high blood pressure and reflux.
Key facts
- Status:
- Active
- Region
:
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa, North Africa
- Countries:
- Tunisia
- Sector
:
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.
- Health
- Investment type
:
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund:
- A4C S Feeder LP
- Fund Manager:
- Actis LLP
- Start date
:
For direct investments, this is the date British International Investment committed capital to the business or project.
For funds, this is the date that British International Investment committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- August 2016
- Domicile
:
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
- Tunisia
